1-(2-羟乙基)-4-(3-羟丙基)哌啶 | 19780-85-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 1-(2-羟乙基)-4-(3-羟丙基)哌啶
• 中文别名: 1-[2-氨基-1-(2-氨基苯基)乙基]吡咯烷-3-羧酸；1-乙醇-4-丙醇哌啶
• 英文名称: 1-(2-hydroxyethyl)-4-(3-hydroxypropyl)piperidine
• 英文别名: N-Hydroxyethyl-4-propanol-piperidin；1-(2-hydroxyethyl)piperidine-4-propanol；4-Piperidinepropanol, 1-(2-hydroxyethyl)-；3-[1-(2-hydroxyethyl)piperidin-4-yl]propan-1-ol
• CAS: 19780-85-9；52005-98-8
• 化学式: C₁₀H₂₁NO₂
• mdl: MFCD00047481
• 分子量: 187.282
• InChiKey: QCZXNEGHMZUDNS-UHFFFAOYSA-N

物化性质

• 熔点：
  46.0 to 51.0 °C
• 沸点：
  316.0±12.0 °C(Predicted)
• 密度：
  1.016±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  43.7
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 安全说明：
  S26,S36
• 危险类别码：
  R36/37/38
• 海关编码：
  2933399090

文献信息

• Novel benzothiazepine and bensothiepine compounds
  申请人：Sasahara Takehiko

  公开号：US20070190041A1

  公开（公告）日：2007-08-16

  A pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, and a pharmaceutical useful as a therapeutic agent and a preventive agent for hepatic disorders associated with cholestasis, particularly, primary biliary cirrhosis and primary sclerosing cholangitis, and a pharmaceutical useful as a therapeutic agent and a preventive agent for obesity, fatty liver and steatohepatitis are provided. A benzothiazepine or benzothiepine compound represented by the following formula (1A) having a thioamide bond and a quaternary ammonium substitutent:

  提供了一种药物，可用作治疗和预防高脂血症的治疗剂和预防剂，以及一种药物，可用作治疗和预防与胆汁淤积有关的肝脏疾病，特别是原发性胆汁性肝硬化和原发性硬化性胆管炎的治疗剂和预防剂，以及一种药物，可用作治疗和预防肥胖症、脂肪肝和脂肪性肝炎的治疗剂和预防剂。化合物的苯并噻吩或苯并噻环代表如下式（1A），具有硫酰胺键和季铵取代基：
• Novel quaternary ammonium compounds
  申请人：Sasahara Takehiko

  公开号：US20070203115A1

  公开（公告）日：2007-08-30

  A method for inhibiting ileal bile acid transporter activity in a subject, comprising administering to said subject an effective amount of a compound represented by formula (1):

  一种抑制回肠胆汁酸转运蛋白活性的方法，包括向该受试者施用一种由式（1）所代表的化合物的有效量：
• Photo-sensitive polymer composition
  申请人：HITACHI, LTD.

  公开号：EP0475086A1

  公开（公告）日：1992-03-18

  A photo-sensitive polymer composition comprising (a) a polymer obtained by reacting a poly(amic acid) with one or more amino compounds having at least one hydroxyl group and an isocyanate compound, and (b) one or more photosensitizers, photoinitiators or photocrosslinkers can provide a polyimide film excellent in heat resistance and mechanical properties and is suitable for forming fine patterns.

  一种光敏聚合物组合物由以下部分组成：(a) 聚（氨基）酸与一种或多种具有至少一个羟基的氨基化合物和异氰酸酯化合物反应得到的聚合物；(b) 一种或多种光敏剂、光引发剂或光交联剂。
• Low odor environmentally-friendly nano-pigment inkjet ink composition
  申请人：JETBEST Corporation

  公开号：EP2617779A1

  公开（公告）日：2013-07-24

  A low odor environmentally-friendly nano-pigment inkjet ink composition has good storage stability, inkjet stability, and good print quality. The printhead nozzles are not easily clogged by such an inkjet ink composition. The printed image has high gloss, scratch resistance, and weather resistance. The inkjet ink composition using low toxic and low odor raw material has a high flash point, and has high security to human health and environment. The inkjet ink composition can meet both the environmental requirement and the print quality requirement. The inkjet ink composition includes 1-10% of N-ethyl pyrrolidone, 1-20% propylene carbonate, 50-80% glycol ether solvent, pigment, dispersant, resin, plasticizer, surfactant, and cyclic tertiary amine compound as an acidity regulator.

  一种低气味的环保型纳米颜料喷墨墨水组合物具有良好的储存稳定性、喷墨稳定性和良好的打印质量。这种喷墨墨水成分不易堵塞喷头喷嘴。打印图像具有高光泽度、抗划伤性和耐候性。使用低毒、低气味原料的喷墨墨水组合物闪点高，对人体健康和环境的安全性高。喷墨墨水成分既能满足环保要求，又能满足打印质量要求。喷墨墨水组合物包括 1-10%的 N-乙基吡咯烷酮、1-20%的碳酸丙烯酯、50-80%的乙二醇醚溶剂、颜料、分散剂、树脂、增塑剂、表面活性剂和作为酸度调节剂的环叔胺化合物。
• BIOLOGICAL TISSUE STAINING REAGENT, BIOLOGICAL TISSUE STAINING KIT AND BIOLOGICAL TISSUE STAINING METHOD
  申请人：Cubicstars, Inc.

  公开号：EP4001888A1

  公开（公告）日：2022-05-25

  A biological tissue-staining reagent includes a nonionic surfactant at a concentration higher than 1%, and a salt at not less than 200 mM.

  生物组织染色试剂包括浓度高于 1%的非离子表面活性剂和不低于 200 毫摩尔的盐。

表征谱图